Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹2,929 Cr₹3,812 Cr₹2,903 Cr₹2,560 Cr

What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?

The latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA is ₹2,929 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹2,929 Cr
Mar2023₹3,812 Cr
Mar2022₹2,903 Cr
Mar2021₹2,560 Cr

How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹2,929 Cr
-23.17
Mar2023 ₹3,812 Cr
31.33
Mar2022 ₹2,903 Cr
13.37
Mar2021 ₹2,560 Cr -

Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹25,520.6 Cr -4.1% -6.9% 22.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,254.0 Cr -2.5% -4.9% 8.7% Stock Analytics
DIVIS LABORATORIES ₹172,374.0 Cr -2.7% -0.9% 42.5% Stock Analytics
CIPLA ₹119,795.0 Cr -1.5% 0.1% -4.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,698.0 Cr -2.6% 8.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,218.0 Cr -2.6% -3.7% 11.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-4.1%

-6.9%

22.4%

SENSEX

-0.4%

0.2%

5.9%


You may also like the below Video Courses